Drug safety physician with more than 6 years of experience in pharmacovigilance. I am skilled at reviewing safety reports, including case narratives, adverse events, lab, drug, and medical history coding, determining seriousness, expectedness, and listedness, authoring company causality assessments, and requesting follow-up queries as part of assessing and reporting adverse events related to drug use. Solid understanding of FDA, EMA, and Health Canada regulations, the drug development process, and ICH-GCP principles. I have extensive knowledge of medical terminology, MedDRA (Medical Dictionary for Regulatory Activities), and the WHO drug dictionary. Adept at evaluating and presenting medical and clinical data in group discussions. Dynamic, detail-oriented team player with excellent communication and organizational skills.